$SHAKESPEAR

Ticker: GOSS Company Name: Gossamer Bio Inc. Trading @ 10.67 CNN Money Analysts Link: https://money.cnn.com/quote/forecast/forecast.html?symb=GOSS Price Target: $12 - $29 Pipeline: Seralutinib (GB002): Inhaled PDGFR, CSF1R, c-KIT inhibitor; Phase 2 ongoing -What is it? GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) -   Condition:   Pulmonary Arterial Hypertension - Description: The primary objective for this trial is to determine the effect of GB002 on improving pulmonary hemodynamics in subjects with the World Health Organization (WHO) Group 1 PAH who are Functional Class (FC) II and III. The secondary objective for this trials to determine the effect of GB002 on improving exercise capacity in this population. ClinicalTrials.gov: https://clinicaltrials.gov/ct2/show/NCT04456998 Last news:) Pharrmacologic Characterization of GB002, a Novel Inhaled PGGFR Kinase Inhibitor in Development for Pulmonary Arterial Hypertension (PAH ) 2. GB004 - Ulcerative...

When investing from a low level profile, every penny as a loss is a loss that bites. Even when you know a potential ticker will go up, seeing it in the red is bothersome. Needless to say, when you expect or know there is a potential news coming up - there is something to keep in mind. It absolutely does not matter whether the news is good or not. You buy the potential, sell the hype-before-news. The market acts in a very emotional way. People expect good news to come out and buy in, but there are two sides to that coin. The news can be either very good, or very bad. Let's put that into perspective: We will take a pharmaceutical company who has an upcoming drug review. We can use various resources to see that and you can find them listed at the bottom of this post. However, a couple of days prior to this said 'news', you join the flock in loading the stock that is trading at, let's say, $1.00 per share. You expect the shares to skyrocket to $4-5 per share and have put in...